News Release

April 17,2019
The PⅠ/Ⅱa clinical trial of FPP003(Antibody-inducing peptide) starts in Australia.
February 26,2019
FunPep is approved the PⅠ/Ⅱa clinical trial plan of FPP003 (antibody-inducing peptide) by HREC in Australia.
February 18,2019
FunPep contracts the joint research agreement with Shionogi for antibody-inducing peptide on pain territory.

FunPep Co., Ltd.,

151-0051 No.7 Mizuho Building 3F, 5-8-4 Sendagaya Shibuya-ku, Tokyo

Main access route

Yamanote line to Yoyogi Station Walk 5 minutes.
Tokyo Metro Fukutoshin Line to Kita-Sando Station Walk 5 minutes.